Term
|
Definition
"chemotherapy" - agents that selectively kill pathogens. Arsenic compound killed trypanosomes (Afr. Sleep. Sick.) and one for syphilis pathogen |
|
|
Term
|
Definition
staph growing on plate with some mold.. didn't grow around mold. Chain&Florey went further and found out that it was in fact penicillin. |
|
|
Term
|
Definition
term "antibiotic" for naturally produced antimicrobials |
|
|
Term
|
Definition
|
|
Term
4 primary genre that produce antibiotics |
|
Definition
Penicillium, Cephalosporium (fungi)-class with most drugs, Bacillus and Streptomyces (bacteria). Primarily from soil microbes. |
|
|
Term
|
Definition
Antibiotics, semisynthetics ("hybrid"), Synthetics |
|
|
Term
6 main mech of microbial action |
|
Definition
inhibit cell wall synthesis, inhibit protein synthesis, disrupt cell membrane, inhibit metabolic pathways, inhibit nucleic acid synthesis, block target recognition or attachment to host. |
|
|
Term
|
Definition
Inhibit cell wall synthesis. b-lactum antibiotic |
|
|
Term
|
Definition
Inhibit cell wall synthesis. b-lactum antibiotic |
|
|
Term
|
Definition
inhibit cell wall synthesis |
|
|
Term
|
Definition
Inhibit cell wall synthesis |
|
|
Term
|
Definition
inhibit cell wall synthesis (topical) |
|
|
Term
Inhibition of cell wall synthesis works only on |
|
Definition
G+ reproducing quickly (keep cells from increasing amount of cell wall material in log phase. No effects on animal cells(no cell wall) or plant cells (no ppg). |
|
|
Term
Isoniazid (INH) and ethambutol |
|
Definition
Effect mycobacterium (arabinogalactan-mycolic acid layer) disrupt layer. long term because of long generation time. |
|
|
Term
Inhibition of protein synthesis |
|
Definition
|
|
Term
|
Definition
Aminoglycoside - inhibit protein synthesis |
|
|
Term
|
Definition
Aminoglycoside - inhibit protein synthesis |
|
|
Term
|
Definition
Aminoglycoside - inhibit protein synthesis |
|
|
Term
|
Definition
Aminoglycoside - inhibit protein synthesis |
|
|
Term
|
Definition
Inhibit protein synthesis |
|
|
Term
|
Definition
Macrolide - inhibit protein synthesis |
|
|
Term
|
Definition
Macrolide - inhibit protein synthesis |
|
|
Term
|
Definition
Tetracycline - inhibit protein synthesis |
|
|
Term
|
Definition
Tetracycline - inhibit protein synthesis |
|
|
Term
|
Definition
Tetracycline - inhibit protein synthesis |
|
|
Term
|
Definition
tetracycline - inhibit protein synthesis |
|
|
Term
|
Definition
Oxazolidinones - inhibit protein synthesis |
|
|
Term
Dalfopristine/Quinupristine |
|
Definition
Streptogramin - inhibit protein synthesis |
|
|
Term
|
Definition
polyenes - Fungi not bacteria - disrupt membrane |
|
|
Term
|
Definition
G- topical, disrupt membrane |
|
|
Term
|
Definition
inhibit metabolic pathways |
|
|
Term
|
Definition
Sulfonamides - inhibit metabolic pathways |
|
|
Term
|
Definition
Antiviral - inhibition of metabolic pathways |
|
|
Term
|
Definition
Antiviral - inhibit metabolic pathways |
|
|
Term
|
Definition
Quinolones/Fluoroquinolones - Inhibit NA synthesis |
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
Characteristics of ideal antimicrobial: |
|
Definition
Readily available, inexpensive, chemically stable, easily administered (oral), Nontoxic and non-allergenic, selectively toxic against variety of pathogens. |
|
|
Term
Clinical considerations in prescribing antimicrobial drugs: |
|
Definition
Spectrum of Action, Ifficacy, Routes of administration, Safety and Side effects. |
|
|
Term
|
Definition
Narrow - Few kinds of pathogens. Broad - Many diff kinds of pathogens. Narrow spectrum preferred. Side effects - kill flora too. |
|
|
Term
|
Definition
1. Diffusion Susceptibility Test (kirby-bauer) swab Muller-Hinton agar, add disks, measure zones, use table. 2. Minimum Inhibitory Concentration Test - broth dilution test (Etest - zones and MIC on 1 plate) |
|
|
Term
|
Definition
Topical, intravenous, intramuscular, oral. |
|
|
Term
|
Definition
Side effects - Toxicity, Allergies (Anaphylactic Shock-vessels dilate and leak.Can lose allergy over time), Disruption of normal flora (opportunistic or superinfections). |
|
|
Term
|
Definition
acquired through mutations or plasmid acquisition. |
|
|
Term
|
Definition
1. Produce an enzyme that destroys drug. 2. Slow/block entry. 3. Alter receptor for drug. 4. Utilize alternate metabolic pathways. 5. Pump drug out of cell. |
|
|
Term
|
Definition
More than one drug (diff classes). r-plasmid exchange. Hospital and nursing homes cause week Immune system, lots of antibiotic use, lots of pathogens. |
|
|
Term
|
Definition
2 or more drugs same family |
|
|